Meet Some of the Physicians
and Cervical Spinal Cord
Injury Patients in the
AST-OPC1 Clinical Trial

Scientific Presentations

Dendritic Cell

Dendritic Cell Immunotherapy

  • Stimulates diverse immune responses to extend remission

Telomerase Antigen


  • Universal cancer antigen, conferring proliferative ability
  • Normal adult cells do not express telomerase, ensuring safety

LAMP Protein


  • LAMP enhances antigen presentation by dentritic cells to increase immune response
  • Licensed from Immunomic Therapeutics

Sep 14, 2016
ISCoS meeting 2016
Initial Clinical Trials of hESC-Derived Oligodendrocyte Progenitor Cells in Subacute Spinal Cord Injury

May 30, 2015
Khoury et al ASCO AST-VAC1 Presentation
Long-term Follow-up of Patients with Acute Myelogenous Leukemia Receiving an Autologous Telomerase-based Dendritic Cell Vaccine

May 22, 2014
American Society for Gene and Cell Therapy Annual Meeting, Washington, DC
Phase I Clinical Trial of Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors in Patients with Neurologically Complete Thoracic Spinal Cord Injury: Results and Next Steps

Asterias Biotherapeutics Tel: (510) 456-3800